[HTML][HTML] The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report
Purpose Because current approaches to risk classification and treatment stratification for
children with neuroblastoma (NB) vary greatly throughout the world, it is difficult to directly …
children with neuroblastoma (NB) vary greatly throughout the world, it is difficult to directly …
[HTML][HTML] The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts
…, JM Zucker, GM Lenoir, PF Ambros… - … England Journal of …, 1994 - Mass Medical Soc
Background Precise diagnosis of small-round-cell tumors is often a challenge to the
pathologist and the clinical oncologist. In Ewing's sarcomas and related peripheral primitive …
pathologist and the clinical oncologist. In Ewing's sarcomas and related peripheral primitive …
[HTML][HTML] The international neuroblastoma risk group (INRG) staging system: an INRG task force report
T Monclair, GM Brodeur, PF Ambros… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose The International Neuroblastoma Risk Group (INRG) classification system was
developed to establish a consensus approach for pretreatment risk stratification. Because the …
developed to establish a consensus approach for pretreatment risk stratification. Because the …
MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and …
This study reports on the specific expression of the MIC2 gene, a pseudoautosomal gene
located on the short arms of the X and Y chromosomes, on Ewing's sarcoma (ES) and …
located on the short arms of the X and Y chromosomes, on Ewing's sarcoma (ES) and …
[HTML][HTML] Advances in risk classification and treatment strategies for neuroblastoma
…, PF Ambros, A Nakagawara, F Berthold… - Journal of clinical …, 2015 - ncbi.nlm.nih.gov
Risk-based treatment approaches for neuroblastoma have been ongoing for decades.
However, the criteria used to define risk in various institutional and cooperative groups were …
However, the criteria used to define risk in various institutional and cooperative groups were …
The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro
…, AL Komaroff, PF Ambros… - Proceedings of the …, 2010 - National Acad Sciences
Previous research has suggested that human herpesvirus-6 (HHV-6) may integrate into
host cell chromosomes and be vertically transmitted in the germ line, but the evidence—primarily …
host cell chromosomes and be vertically transmitted in the germ line, but the evidence—primarily …
Chromosomally integrated human herpesvirus 6: questions and answers
PE Pellett, DV Ablashi, PF Ambros… - Reviews in medical …, 2012 - Wiley Online Library
Chromosomally integrated human herpesvirus 6 (ciHHV‐6) is a condition in which the
complete HHV‐6 genome is integrated into the host germ line genome and is vertically …
complete HHV‐6 genome is integrated into the host germ line genome and is vertically …
[HTML][HTML] Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project
…, V Castel, T Monclair, PF Ambros… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Survival after neuroblastoma relapse is poor. Understanding the relationship between
clinical and biologic features and outcome after relapse may help in selection of optimal …
clinical and biologic features and outcome after relapse may help in selection of optimal …
[HTML][HTML] Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
…, M Bernkopf, S Taschner-Mandl, IM Ambros… - Nature …, 2021 - nature.com
Sequencing of cell-free DNA in the blood of cancer patients (liquid biopsy) provides
attractive opportunities for early diagnosis, assessment of treatment response, and minimally …
attractive opportunities for early diagnosis, assessment of treatment response, and minimally …
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international …
Background High-dose chemotherapy with haemopoietic stem-cell rescue improves event-free
survival in patients with high-risk neuroblastoma; however, which regimen has the …
survival in patients with high-risk neuroblastoma; however, which regimen has the …